Tyra Biosciences (TYRA) Non Operating Income (2020 - 2026)

Tyra Biosciences (TYRA) has 7 years of Non Operating Income data on file, last reported at $2.7 million in Q1 2026.

• Quarterly Non Operating Income fell 27.28% year-over-year to $2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.8 million (down 31.74% YoY) and the FY2025 annual result came in at $12.8 million, down 27.58% from the prior year.
• Non Operating Income steadied at $2.7 million in Q1 2026, from $2.7 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $4.8 million in Q2 2024 to a low of $8000.0 in Q1 2022.
• A 5-year average of $2.8 million and a median of $2.8 million in 2023 frame the typical range for Non Operating Income.
• Annual changes were most pronounced in 2022 — Non Operating Income surged 106050.0% — and 2025, when it slumped 35.73%.
• Tracing TYRA's Non Operating Income over 5 years: stood at $2.1 million in 2022, then jumped by 32.08% to $2.8 million in 2023, then jumped by 48.82% to $4.2 million in 2024, then tumbled by 35.73% to $2.7 million in 2025, then grew by 0.41% to $2.7 million in 2026.
• The last three Non Operating Income figures came in at $2.7 million (Q1 2026), $2.7 million (Q4 2025), and $3.1 million (Q3 2025), per Business Quant data.